This evidence, together with the results of our study, supports the hypothesis that piperine may have bound to these mediators, preventing the binding of IL-1β to its receptor and the synthesis of PGE2, and resulting in an anti-inflammatory and antitumor effect in the tumor cells (Figure 8). The gene discussed is IL1B; the disease is neoplasm.